SCHEMBL15568638

SCHEMBL15568638

O=S(=O)(NC1CCN(c2nc3ccccc3n2Cc2cccc(F)c2)CC1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HRH1 P35367 10/20 0.50
▸ CYP2D6 P10635 9/20 0.50
▸ CHRM1 P11229 4/20 0.50
▸ PPARG P37231 4/20 0.46
▸ KCNH2 Q12809 4/20 0.46
▸ CCR3 P51677 1/20 0.45
▸ ALDH1A2 O94788 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ ALDH2 P05091 1/20 0.45
▸ ALDH3A1 P30838 1/20 0.45
▸ ALDH1A3 P47895 1/20 0.45
▸ HTR1A P08908 1/20 0.44
▸ HTR7 P34969 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15567868 0.89 HRH1 (0.51) HRH1CYP2D6CHRM1KCNH2ALDH1A2
SCHEMBL15568004 0.86 HRH1 (0.51) HRH1CYP2D6CHRM1PPARGKCNH2
SCHEMBL15567781 0.86 HRH1 (0.55) HRH1CYP2D6CHRM1KCNH2CCR3
SCHEMBL15569123 0.84 HRH1 (0.53) HRH1CYP2D6CHRM1KCNH2CCR3
SCHEMBL15567224 0.83 HRH1 (0.55) HRH1CYP2D6CHRM1KCNH2
SCHEMBL15569414 0.83 HRH1 (0.56) HRH1CYP2D6CHRM1KCNH2
SCHEMBL15568082 0.82 HRH1 (0.47) HRH1CYP2D6CHRM1KCNH2CCR3
SCHEMBL15568411 0.82 HRH1 (0.48) HRH1CYP2D6CHRM1KCNH2CCR3
SCHEMBL15567989 0.81 HRH1 (0.54) HRH1CYP2D6CHRM1KCNH2ALDH1A1
SCHEMBL15567917 0.81 HRH1 (0.62) HRH1CYP2D6CHRM1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014027053-A1 BENZIMIDAZOLES FOR THE TREATMENT OF CANCER MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2014-02-20 — — WO disclosed
Send feedback